Bin hier ausgestiegen, ist mir zu langweilig :roll:
ALXA offeriert Aktien super Gelegenheit um günstig Aktien zu kaufen. :):) mal sehn wo sie sich stabilisiert. aber Focus bleibt auf AVNR...
Form 8-K for ALEXZA PHARMACEUTICALS INC.
5-Aug-2010
Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement.
On August 4, 2010, Alexza Pharmaceuticals, Inc. ("Alexza") entered into a placement agent agreement with RBC Capital Markets Corporation and JMP Securities LLC (the "Placement Agents") relating to Alexza's registered direct offering, issuance and sale of 
up to 6,685,183 shares of Alexza's common stock and (b) warrants to purchase up to 3,342,589 shares of Alexza's common stock with an exercise price of $3.30 per share. The shares of common stock and the warrants will be sold in units, with each unit consisting of one share of common stock and a warrant to purchase 0.5 of a share of common stock, at an offering price of $2.70 per unit. Under the terms of the offering, Alexza will issue and sell the units to certain institutional investors (the "Investors") for gross proceeds of approximately $18.0 million. Pursuant to the terms of the placement agent agreement, Alexza has agreed to pay the Placement Agents a commission equal to 6.0% of the gross proceeds from the offering. The offering is being made pursuant to subscription agreements between Alexza and each of the Investors. The closing of the offering is expected to take place on August 10, 2010, subject to the satisfaction of customary closing conditions. The net offering proceeds to Alexza from the sale of the units will be approximately $16.4 million, after deducting the Placement Agents' commissions and estimated offering expenses payable by Alexza.
The foregoing descriptions of the placement agent agreement, warrants and subscription agreements do not purport to be complete and are qualified in their entirety by reference to the placement agent agreement, form of warrant and form of subscription agreement that are attached to this report as Exhibit 1.1, 4.1 and 99.1, respectively, and are incorporated herein by reference.
The units are being offered and sold pursuant to a prospectus supplement dated August 4, 2010 and an accompanying base prospectus dated May 26, 2010, pursuant to Alexza's existing shelf registration statement on Form S-3 (File No. 333-166514) that was declared effective by the Securities and Exchange Commission on May 20, 2010. A copy of the opinion of Cooley llprelating to the legality of the issuance and sale of the securities in the offering is attached as Exhibit 5.1 hereto.
On August 5, 2010, Alexza issued a press release announcing the pricing of the offering. A copy of the press release is attached as Exhibit 99.2 hereto and is incorporated herein by reference.
Von mir aus, darf es noch ein wenig runter kommen... avanir hat doch in zwei Wochen auch was, oder?
werde mich kommende woche mit avnr eindecken, alxa ist für mich schon zu spät... mal schaun, chancen jedoch für zulassung sehen gut aus!
Habe schon ein paar ALXA zu 2.62 im Portfolio und überlege gerade nachzukaufen. Die Chancen stehen ja gut. Wie ist der Preisrange wenn am 11.10. alles gut geht?
Widerstand bei ca. 3.87, (4, 5 und 6 USD
Sozusagen sind keine wirklichen Widerstände da. Die Luft nach oben ist stark geöffnet. Die Marktkapitalisierung ist auch relativ klein.
Quote:
QuoteAZ-004 would compete with the injectable form of loxapine and other antipsychotic drugs, such as Eli Lilly's Zyprexa, Johnson & Johnson's Risperdal and AstraZeneca's Seroquel
So, habe mir gerade ein paar ALXA zu 3.45 gegönnt 
Vagnum, hast du am 11. Oktober Geburtstag?
